Literature DB >> 21283032

Propranolol for the treatment of orbital infantile hemangiomas.

Gretta Fridman1, Eric Grieser, Robert Hill, Nausheen Khuddus, Tom Bersani, Charles Slonim.   

Abstract

PURPOSE: To evaluate the treatment of orbital infantile hemangiomas with systemic (oral) propranolol.
METHODS: This study was a retrospective observational case series of 5 infants who were diagnosed with orbital infantile hemangiomas between March and July of 2009.
RESULTS: The average age at presentation was 3.1 months (3 weeks to 9 months). The patients received oral propranolol, with dosage varying among study centers. The patients were treated for an average of 7.1 months. Treatment of 5 infantile hemangioma patients with oral propranolol produced a significant reduction in the size of the hemangioma in 4 (80%) of the patients and a minimal improvement in one patient. No patient had significant adverse events during the treatment period.
CONCLUSION: Oral propranolol may be an effective treatment for orbital infantile hemangiomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283032     DOI: 10.1097/IOP.0b013e318201d344

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

1.  Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.

Authors:  M Snir; U Reich; R Siegel; A Zvulunov; R Friling; N Goldenberg-Cohen; Y Ron; D Ben-Amitay
Journal:  Eye (Lond)       Date:  2011-09-16       Impact factor: 3.775

2.  Typical Orbital Pathologies: Hemangioma.

Authors:  Christopher M Low; Janalee K Stokken
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-19

Review 3.  Initiation and use of propranolol for infantile hemangioma: report of a consensus conference.

Authors:  Beth A Drolet; Peter C Frommelt; Sarah L Chamlin; Anita Haggstrom; Nancy M Bauman; Yvonne E Chiu; Robert H Chun; Maria C Garzon; Kristen E Holland; Leonardo Liberman; Susan MacLellan-Tobert; Anthony J Mancini; Denise Metry; Katherine B Puttgen; Marcia Seefeldt; Robert Sidbury; Kendra M Ward; Francine Blei; Eulalia Baselga; Laura Cassidy; David H Darrow; Shawna Joachim; Eun-Kyung M Kwon; Kari Martin; Jonathan Perkins; Dawn H Siegel; Robert J Boucek; Ilona J Frieden
Journal:  Pediatrics       Date:  2012-12-24       Impact factor: 7.124

4.  Oral propranolol for treatment of pediatric capillary hemangiomas.

Authors:  Maryam Aletaha; Hossein Salour; Abbas Bagheri; Nasrin Raffati; Nassim Amouhashemi
Journal:  J Ophthalmic Vis Res       Date:  2012-04

5.  Recent trends in ocular oncology.

Authors:  Swathi Kaliki; Carol L Shields
Journal:  Oman J Ophthalmol       Date:  2011-09

6.  A clinical update and radiologic review of pediatric orbital and ocular tumors.

Authors:  Ajay A Rao; John H Naheedy; James Y-Y Chen; Shira L Robbins; Hema L Ramkumar
Journal:  J Oncol       Date:  2013-03-12       Impact factor: 4.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.